KISB heads into its May 1 earnings event in an unusual position: the stock is up 16% over the past month, yet short interest has exploded at the same time.
The short interest story here is striking, even though the absolute level is small. Estimated shares short have risen roughly 70% week-on-week to around 320 shares — and the one-month change is a near-vertical climb from a handful of shares in late January. The stock's SI as a percentage of free float remains negligible at 0.01%, so there is no classic squeeze setup, and availability is extremely loose at close to 4,000% of short interest. That means there are no supply constraints in the borrow market. What the data does show, however, is a sudden and sharp uptick in short-selling activity that coincides almost exactly with the stock's rally — the hallmark of new shorts being established against a rising price, not an existing short position being squeezed out.
The borrow market confirms that this is a live and active setup. Cost to borrow has doubled over the past month to roughly 14.8%, which is the highest level seen outside of a brief May 2024 episode when CTB touched 40%. Borrow costs have been volatile day-to-day — swinging between 8% and 15% in the past two weeks — suggesting a thin and contested lending market despite the loose headline availability figure. The ORTEX short score is running at 50.7 out of 100, a middling but upward-trending reading that jumped sharply on April 28 after spending several sessions in the low 30s. The oscillation in both utilization (ranging from near zero to 100% within the same month) and the short score underlines how thin the trading activity is on this OTC-listed micro-cap.
The fundamental picture gives the shorts something to argue with. Q1 2026 results, released on April 14, showed net income of $5.3 million — up 47% year-on-year — with basic EPS of $1.76 versus $1.21 a year ago. Net interest income rose to $16.0 million from $13.1 million. The stock responded with a 1.6% one-day gain and closed the five-day window up 6.5%. That beat is now fully embedded in the price, and the stock at $56 trades at a meaningful premium to the Q1 tangible book value of $41.35. A second earnings event is due May 1, though the data does not yet clarify whether this is an additional release or a rescheduled presentation. Either way, the stock enters the date with a 15% one-month rally already behind it. The two prior earnings prints each generated moves of 5–9% over five days — all positive — so the recent pattern of post-results drifts higher has been consistent.
Dividend data in the snapshot extends only to mid-2022, so no current yield commentary is appropriate here. What the April 2 press release did confirm is a $0.40 quarterly dividend — a meaningful payout for a stock that spent much of 2025 trading in the low-to-mid $40s, and one that has helped attract income-oriented holders on this lightly traded name. Peer regional banks SFNC and OBT both gained 5–6% and 3.5% on the week respectively — directionally in line with KISB's 4.7% weekly gain, suggesting the broader regional bank tape was supportive rather than uniquely driving this move.
The next thing to watch is how the market responds to the May 1 event — and whether the sharp rise in short interest and borrow costs represents genuine conviction against the valuation, or simply thin-market positioning noise on a micro-cap with near-zero float being shorted.
See the live data behind this article on ORTEX.
Open KISB on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
